Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.

The American journal of gastroenterology - 1 Mar 2008

Zografos Theodoros A, Liaskos Christos, Rigopoulou Eirini I, Togousidis Elias, Makaritsis Kostantinos, Germenis Anastasios, Dalekos George N

Abstract excerpt

OBJECTIVES: To compare serum adiponectin and tumor necrosis factor (TNF)-alpha among patients with viral liver diseases; to investigate associations of serum adiponectin and TNF-alpha with histological or viral characteristics of chronic hepatitis C (CHC); to investigate adiponectin and TNF-alpha alterations during interferon (IFN)-alpha treatment; and to assess the relationship between serum adiponectin and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adiponectin
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fatty Liver

Share to Hepatitis B, Chronic

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Ribavirin

Share to Tumor Necrosis Factor-alpha

Source

Identifiers

PMID: 18190648
DOI: 10.1111/j.1572-0241.2007.01729.x

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.PMID 18190648Read ↗

Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.Semantic proximity Read ↗

Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4.Semantic proximity Read ↗

Association of serum adipocytokines with hepatic steatosis and fibrosis in patients with chronic hepatitis C.Semantic proximity Read ↗

Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.Semantic proximity Read ↗

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.Semantic proximity Read ↗

The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4.Semantic proximity Read ↗

Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.Semantic proximity Read ↗

The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.Semantic proximity Read ↗

Serum level of adiponectin correlated with gender and genotype in patients with chronic hepatitis C.Semantic proximity Read ↗

Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.Semantic proximity Read ↗

Elevated serum levels of adiponectin and interlukin-28B after IFN/RIB therapy in hepatitis C virus-infected patients.Semantic proximity Read ↗

Adiponectin changes in HCV-Genotype 4: relation to liver histology and response to treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.